WEN Attorneys Meet With Top FDA Officials In ‘Continued Cooperation’

CFSAN Director Susan Mayne and other high-level FDA officials met with Guthy-Renker and WEN leadership and outside attorneys in September. The substance of the meeting is being kept under wraps, but it shows FDA’s continued involvement in the WEN issue, which drove discussion at the recent Senate HELP Committee hearing on cosmetics.

FDA’s work to address safety issues surrounding WEN Cleansing Conditioners continued in September with a meeting between top agency brass, WEN leadership and a team of prominent attorneys representing the beleaguered brand.

In a statement to the Rose Sheet, a spokesman for WEN manufacturer Guthy-Renker said the meeting “was a continuation of...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Ingredients & Safety

More from HBW Insight